Reports
Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Sale
The global hemostats market is expected to grow at a CAGR of 6.4% in the forecast period of 2021-2026 to reach a value of approximately USD 5.2 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on end use, hospitals account for a significant share in the hemostats industry. This can be attributed to its advanced consumer penetration and ease of care, especially in rural areas. In this case, hospitals have also proved to be a competent option. In addition, some of the major drivers for the hospital and surgical centres segment is projected to be the increasing focus on reducing surgical and post-surgical spending and the increasing prevalence of cardiovascular diseases.
Region-wise, the Asia Pacific is expected to witness a robust growth over the forecast period owing to the high number of surgeries being conducted in the hospitals. The growth can also be attributed to the market expansion by the major players and the presence of significant untapped opportunities in the region. In addition, investment in the healthcare sector has gained momentum, especially in Japan, India, and China. These countries are increasingly focused on building comprehensive surgical clinics and recovery healthcare facilities. These variables are anticipated to contribute to the market growth in the coming years.
A hemostat (also called a hemostatic clamp, or arterial forceps) is a surgical device used to manage bleeding in certain surgical procedures. For this purpose, it is normal to be lined with hemostats that close blood vessels waiting for ligation in the initial phase of surgery for initial incision. Haemostats belong to a category of pivoting instruments (similar to scissors and include needle holders, tissue holders, and separate clamps) where the purpose is determined by the structure of the blade. The hemostat has handles, which, by their locking mechanism, can be kept in place.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the market is divided into:
Based on formulation, the market is categorised into:
On the basis of indication, the market is divided into:
Based on application, the market is segmented into:
By end use, the market is categorised into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
With the rise in people suffering from chronic diseases, the hemostats industry is at an all-time high. The citizens all over the world have shifted to a sedentary lifestyle which is leading to obesity, diabetes, and other lifestyle disorders. Furthermore, the increasing number of surgical procedures with the growing occurrence of trauma and accidents is also aiding the industry growth. The rise in poor lifestyle combined with the technological advancements in the healthcare sector is likely to increase the demand for hemostats, thus, significantly contributing to the market. Further, the reimbursement policies offered by the government has impacted the industry in a positive way. Over the forecast period, rise in demand for surgeries and the technological developments are expected to favour the industry growth.
The report gives a detailed analysis of the following key players in the global hemostats market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Hemostats Market Analysis
8.1 Key Industry Highlights
8.2 Global Hemostats Historical Market (2016-2020)
8.3 Global Hemostats Market Forecast (2021-2026)
8.4 Global Hemostats Market by Product
8.4.1 Combination
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Thrombin-Based
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Gelatin-Based
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Collagen-Based
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2016-2020)
8.4.4.3 Forecast Trend (2021-2026)
8.4.5 Oxidised Regenerated Cellulose Based
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2016-2020)
8.4.5.3 Forecast Trend (2021-2026)
8.4.6 Others
8.5 Global Hemostats Market by Formulation
8.5.1 Sheet and Pad
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Sponge
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 Matrix and Gel
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2016-2020)
8.5.3.3 Forecast Trend (2021-2026)
8.5.4 Powder
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2016-2020)
8.5.4.3 Forecast Trend (2021-2026)
8.5.5 Others
8.6 Global Hemostats Market by Indication
8.6.1 Surgery
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Wound Closure
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Others
8.7 Global Hemostats Market by Application
8.7.1 Cardiovascular Surgery
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2016-2020)
8.7.1.3 Forecast Trend (2021-2026)
8.7.2 General Surgery
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2016-2020)
8.7.2.3 Forecast Trend (2021-2026)
8.7.3 Gynaecological Surgery
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2016-2020)
8.7.3.3 Forecast Trend (2021-2026)
8.7.4 Orthopaedic Surgery
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2016-2020)
8.7.4.3 Forecast Trend (2021-2026)
8.7.5 Reconstructive Surgery
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2016-2020)
8.7.5.3 Forecast Trend (2021-2026)
8.7.6 Neurological Surgery
8.7.6.1 Market Share
8.7.6.2 Historical Trend (2016-2020)
8.7.6.3 Forecast Trend (2021-2026)
8.7.7 Others
8.8 Global Hemostats Market by End Use
8.8.1 Clinics
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2016-2020)
8.8.1.3 Forecast Trend (2021-2026)
8.8.2 Hospitals
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2016-2020)
8.8.2.3 Forecast Trend (2021-2026)
8.8.3 Ambulatory Centres
8.8.3.1 Market Share
8.8.3.2 Historical Trend (2016-2020)
8.8.3.3 Forecast Trend (2021-2026)
8.8.4 Others
8.9 Global Hemostats Market by Region
8.9.1 Market Share
8.9.1.1 North America
8.9.1.2 Europe
8.9.1.3 Asia Pacific
8.9.1.4 Latin America
8.9.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country Kingdom
9.2.3.1 United
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Teleflex Incorporated
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 B. Braun Melsungen AG
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Integra LifeSciences Corporation.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Pfizer Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Baxter International, Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Johnson & Johnson Services, Inc.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Hemostats Market: Key Industry Highlights, 2016 and 2026
2. Global Hemostats Historical Market: Breakup by Product (USD Billion), 2016-2020
3. Global Hemostats Market Forecast: Breakup by Product (USD Billion), 2021-2026
4. Global Hemostats Historical Market: Breakup by Formulation (USD Billion), 2016-2020
5. Global Hemostats Market Forecast: Breakup by Formulation (USD Billion), 2021-2026
6. Global Hemostats Historical Market: Breakup by Indication (USD Billion), 2016-2020
7. Global Hemostats Market Forecast: Breakup by Indication (USD Billion), 2021-2026
8. Global Hemostats Historical Market: Breakup by Application (USD Billion), 2016-2020
9. Global Hemostats Market Forecast: Breakup by Application (USD Billion), 2021-2026
10. Global Hemostats Historical Market: Breakup by End Use (USD Billion), 2016-2020
11. Global Hemostats Market Forecast: Breakup by End Use (USD Billion), 2021-2026
12. Global Hemostats Historical Market: Breakup by Region (USD Billion), 2016-2020
13. Global Hemostats Market Forecast: Breakup by Region (USD Billion), 2021-2026
14. North America Hemostats Historical Market: Breakup by Country (USD Billion), 2016-2020
15. North America Hemostats Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Europe Hemostats Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Europe Hemostats Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Asia Pacific Hemostats Historical Market: Breakup by Country (USD Billion), 2016-2020
19. Asia Pacific Hemostats Market Forecast: Breakup by Country (USD Billion), 2021-2026
20. Latin America Hemostats Historical Market: Breakup by Country (USD Billion), 2016-2020
21. Latin America Hemostats Market Forecast: Breakup by Country (USD Billion), 2021-2026
22. Middle East and Africa Hemostats Historical Market: Breakup by Country (USD Billion), 2016-2020
23. Middle East and Africa Hemostats Market Forecast: Breakup by Country (USD Billion), 2021-2026
24. Global Hemostats Market Structure
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.